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DEFICIT/HYPERACTIVITY DISORDER (ADHD) 
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Salvatore Corbisiero, Beatrice Mörstedt  
and Berit Oetsch 
The University of Basel, Switzerland 
 
 
ABSTRACT 
 
The hallmarks of Attention-Deficit/Hyperactivity Disorder (ADHD) are reflected in 
the symptom areas of inattention, impulsivity and hyperactivity. ADHD was long 
regarded as a childhood disease, but various studies have since found that adults are 
equally affected by the disorder. Differential diagnostic considerations, therefore, as well 
as the need for regard to potential comorbidity are of great importance for the diagnostic 
process. As possible examples are mentioned autism spectrum disorder, substance use 
disorders, schizophrenia, affective disorders, anxiety disorders and personality disorders. 
These groups of disorder form the subject of discussion in this chapter. 
 
 
1. INTRODUCTION 
 
The hallmarks of Attention-Deficit/Hyperactivity Disorder (ADHD) are reflected in the 
symptom areas of inattention, impulsivity and hyperactivity. ICD-10 subdivides these 
symptom areas into those of simple impaired activity and attention deficit disorder (F90.0: 
disturbance of activity and attention), hyperkinetic disorder with impaired social interaction 
(F90.1: hyperkinetic conduct disorder), other hyperkinetic disorders (F90.8 or F90.9) and 
attention deficit disorder without hyperactivity (F98.8). Compared to DSM-IV, DSM-5 no 
longer lists explicit subtypes for ADHD but instead focuses on three so-called „specifiers‟ 
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based on predominant phenotypes, i.e., the combined presentation, the predominantly 
inattentive presentation and the predominantly hyperactive-impulsive presentation. 
ADHD was long regarded as a childhood disease, but various studies have since found 
that adults are equally affected by the disorder. It is today believed that around 50% of those 
diagnosed with ADHD during childhood and adolescence continue to be affected by the 
disorder in adulthood. With a world-wide prevalence rate of 1-7%, ADHD represents one of 
the most common disorders in adulthood (de Zwaan et al. 2012; Fayyad et al. 2007; Kessler et 
al. 2006). Figures for prevalence rates vary considerably depending on the country and the 
samples researched. With a gender ratio of 1.6:1, more men than women are affected by the 
disorder in adulthood (Stieglitz et al. 2012). 
In the context of phenomenology, the diagnostic criteria relate to symptoms which also 
feature as diagnostic criteria for other disorders or which can frequently appear as concurrent 
clinical phenomena. Thus, for example concentration difficulties represent a diagnostic 
criterion for manic and depressive episodes but can occur equally with many mental disorders 
(e.g., schizophrenia). This raises poignant questions in relation to the differential diagnostic 
process. In addition, ADHD shows a high frequency of comorbidity with a series of other 
disorders with estimated prevalence rates reaching a figure of as high as 80%. This is 
important because comorbid patients represent a substantial number of people in treatment 
and present greater disorder severity from both the clinical and social perspectives than those 
people diagnosed with only one type of disorder (Torrens et al. 2012: 1005). 
Differential diagnostic considerations, therefore, as well as the need for regard to 
potential comorbidity are of great importance for the diagnostic process. DSM-5, for 
example, at criterion E carries a reference to the fact that ADHD symptoms are not 
exclusively particular to schizophrenia or other psychotic disorders but may be explained in 
the context of other mental disorders. As possible examples are mentioned autism spectrum 
disorder, substance use disorders, schizophrenia, affective disorders, anxiety disorders and 
personality disorders. These groups of disorder form the subject of discussion in this article. 
 
 
2. DIAGNOSTICS OF ADHD 
 
Compared to other disorders, the diagnostic process of ADHD in adulthood presents 
itself as rather more complex. This is not so much for psychopathological reasons but rather 
as a result of the lifespan perspective which warrants particular consideration, as is similarly 
the case with personality disorders. The following factors can in some cases render 
establishing a diagnosis difficult: 
 
 The root of the symptoms must be sought in childhood. This is particularly important 
on account of the fact that many adult ADHD patients were never diagnosed during 
childhood or adolescence. 
 As a consequence, the patient‟s own reliable personal memories or those of third 
parties involved (e.g., parents) play a significant role in the diagnostic process. 
 Additional sources of data such as school reports must form part of the assessment 
process. School reports are, however, often not available or limited to lists of grades 
only which are of little value. The availability of detailed accounts of displays of 
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irregular forms of behaviour (e.g., disruptive behaviour in class, absent-mindedness) 
or performance levels (eg. concentration problems) is rare. 
 Testing for potential comorbidities is essential. 
 
Weiss et al. (1999) recommend various practical steps to be included in the diagnostic 
process which do not mandatorily need to be followed in the order listed here: the clinical 
interview, testing for ADHD symptoms through the implementation of rating scales, testing 
for other psychiatric disorders, testing for symptoms in childhood, further tests, and the 
recording of impairments. 
Step 1: The clinical interview. The purpose of the clinical interview is to document the 
patient and their life history as well as their present life experience and behaviour. It serves to 
diagnose ADHD symptoms and other disorders and to evaluate the patient‟s current level of 
functioning. 
Step 2: Testing for ADHD symptoms through the implementation of rating scales. Rating 
scales in the form of self-evaluation and third party evaluation procedures can facilitate the 
quantification of present and past symptoms. 
Step 3: Testing for other psychiatric disorders. As already mentioned, prevalence rates of 
comorbidity with other psychiatric disorders are high. Comprehensive screening for other 
psychiatric disorders is therefore of primary importance. Where indications of other 
psychiatric disorders exist, diagnostic criteria of potential comorbid disorder(s) require 
thorough examination (e.g., in the form of diagnostic interviews). 
Step 4: Testing for symptoms in childhood. A diagnosis for ADHD in adulthood is based 
on information relating to the patient‟s childhood. Adults diagnosed with ADHD often relate 
extremely vivid childhood memories. Noteworthy examples are e.g., emotional reactions of 
teachers and parents. 
In cases where patients find it difficult to recall childhood memories, the examining 
clinician is forced to rely on external sources of information. Consulting school reports can in 
some cases yield fruitful results. The implementation of diagnostic scales may further assist 
the diagnostic process. 
Step 5: Further tests. Although there are no compulsory testing procedures to assess a 
patient‟s levels of performance in order to establish an ADHD diagnosis, such tests can 
nevertheless deliver useful supplementary information. These include e.g., (neuro-
)psychological examinations in relation to performance levels in either pencil-and-paper or 
computerised forms. Such tests, however, are no replacement for the clinical interview and 
the rating and recording of the psychopathology by means of specific scales. 
Step 6: Recording of impairments. As ADHD is accompanied by various impairments, 
differentiated investigation into possible affected areas such as quality of life, family situation 
or work, personal relationships, education and training as well as activities in everyday life is 
necessary. Here, too, the use of rating scales may prove helpful. 
As with other mental disorders, the starting point of the diagnostic process for ADHD lies 
in the careful recording of a patient‟s medical history, whereby with ADHD special regard 
must be paid to certain particularities and additional aspects. Table 1 summarises the most 
important areas in relation to medical history-taking as well as supplementary diagnostic 
findings. 
The core areas of a medical history in ADHD cases are similar to those of medical 
histories in cases of other disorders (e.g., family medical history, physical illnesses). 
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Table 1. Diagnostic components of adult ADHD 
 
 complete psychiatric anamnesis  
 ADHD-specific contents of the interview  
 differential diagnoses and comorbidities  
 exclusion of organic mental disorders 
 internistic and neurological examination  
 interview with parents and/or care givers  
 complete ADHD related psychometric assessment 
 neuropsychological assessment 
 
The following aspects require special attention: 
 
 (early) Childhood development: e.g., complications at birth, irregularities observed 
already before school age (such as delayed development) 
 School: e.g., problems during class and with homework, problems with discipline, 
behavioural problems, comments in school reports, early diagnostic assessment 
 Work: e.g., training and education, recurring difficulties, change of work place 
 
Psychological testing procedures can, in view of the assessment targets discussed, 
contribute usefully to the diagnostic process. In keeping with general conventions, a diagnosis 
for ADHD is secured at the start of a course of therapy. Although it is widely accepted today 
that a diagnosis ultimately represents a clinical diagnosis, the results of psychological 
examination procedures can contribute important elements. This is especially the case with 
procedures developed in close association with a classification system. Depending on the 
procedure, individual diagnostic symptom criteria are recorded and in some cases quantified, 
as are aspects of the impairment. 
No direct diagnoses can be derived from neuropsychological procedures as there are, so 
far, no specific procedures available for this, and the multifarious facets of the disorder are 
not specifiable solely by means of neuropsychological procedures. The results of a 
neuropsychological examination can, however, yield supplementary information (see the 
sections below). Specific deficits become recognisable and quantifiable. Following the 
establishment of a diagnosis for ADHD and before medical regulation of the disorder with 
stimulants or other suitable substances, a thorough clinical somatic examination is required. 
This consists of a somatic medical history, a physical medical examination as well as 
laboratory tests. In addition, further examinations may be undertaken as deemed necessary. 
Especially with adult ADHD patients, consideration must be given to a wider spectrum of 
potential comorbid disorders. Some of these may develop as secondary disorders as a result of 
repeated and sustained experiences of frustration and failure over many years (e.g., 
depressions, disorders provoked through psychotropic substance abuse). Other mental 
disorders also typically have their onset in adolescence or in early adulthood. Noteworthy are 
e.g., personality disorders, especially borderline personality disorder, but also schizophrenia. 
These may be comorbid but must equally be considered as possible differential diagnoses for 
other disorders. Adults in particular are also prone to suffer from physical illnesses which 
display ADHD-like symptoms such as hypothyreosis or hyperthyreosis, diabetes or certain 
heart conditions. 
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3. ADHD AND OTHER PSYCHIATRIC DISORDERS 
 
3.1. ADHD and Autism Spectrum Disorders 
 
3.1.1. Prevalence 
In both ADHD and Autism Spectrum Disorder (ASD) cases the majority of children 
affected continue to fulfil the diagnostic criteria for these disorders also in adulthood. With 
ADHD, the percentage of cases where symptoms persist through adolescence and into 
adulthood lies between 50-70% (Rasmussen and Gillberg 2000; Biederman et al. 2007), with 
ASD at around 80% (Billstedt et al. 2005; McGovern and Sigman 2005), whereby the figures 
vary between studies and the development of individual cases depends on personal and 
environmental factors. Thus the probability of a reduction in the severity of autism symptoms 
during a lifespan in high-functioning autism or Asperger‟s syndrome patients respectively is 
markedly higher than in cases affected by other forms of autism (Kočovská et al. 2013; Helles 
et al. 2014; McGovern and Sigman 2005). 
Prevalence rates of autism spectrum disorders (ASD) in children are estimated at 1% 
(Lehnhardt et al. 2013; Baron-Cohen et al. 2009) with no reliable estimates available so far 
for ASD in adulthood. ADHD with estimated rates of up to 7% (see Section above) is thus a 
more frequently occurring type of disorder than ASD. Among affected children both ASD as 
well as ADHD appear to be more commonly found in boys rather than in girls (Roy et al. 
2009; Kohn and Esser 2008). Prevalence estimates for ASD conditions in childhood indicate 
that for every three diagnosed cases of children at primary school age two remain undetected 
(Baron-Cohen et al. 2009). This suggests that a large number of cases reach adulthood 
remaining undiagnosed. Especially autism sufferers with normal cognitive development can, 
on account of masking their difficulties through effective compensation strategies, remain 
clinically undetected over extended periods of time. It is frequently not until they face special 
life challenges beyond school age such as seeking employment or leaving the parental home 
that their limitations become evident. ASD, although a clinical condition, can, depending on 
symptom severity and level of cognitive ability, allow sufferers to successfully lead a largely 
clinically indifferent life. In DSM-IV and ICD-10, ASD and ADHD diagnoses remain 
mutually exclusive, as a result of which past literature largely ignored comorbidity with both 
these disorders. Only a small number of studies so far have investigated symptoms overlap 
and potential comorbidity of ADHD and ASD. The new DSM-5 permits both diagnoses 
simultaneously and thus also allows for possible comorbidity of both disorders. 
 
3.1.2. Differential Diagnosis 
Core symptoms of autistic disorders are 1) persistent impaired social communication and 
interaction in various contexts and 2) restricted, repetitive range of behaviour patterns, 
interests or activities. Concerning this point DSM-5 now also includes hyper- or hypo-
reactive responses to sensory stimuli or unusually intense levels of interest in environmental 
stimuli. This stands in contrast to DSM-IV which, unlike DSM-5, attributes no significance to 
these issues. Additionally, DSM-5 treats autism as a spectrum disorder, which dispenses with 
the previously necessary differentiation between various subtypes such as Kanner‟s autism, 
atypical autism or Asperger‟s autism. 
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In diagnostic differentiation of ASD from ADHD, it is important to remember that with 
ASD, too, inattention remains an observed symptom (Roy et al. 2013; Lehnhardt et al. 2013). 
While with ADHD attention deficits occur predominantly as a result of increased 
distractibility in response to external stimuli, with ASD such symptoms occur as a 
manifestation of limited inner flexibility in adjusting to changed foci of attention. Equally, 
however, both cases may display an increased in-depth focus of attention in particular areas 
of interest which, in the case of ADHD, emerges as a hyperfocus on a specifically targeted 
interest area, whilst in ASD it manifests itself within the parameters of avidly pursued special 
interests. Impulsivity is a symptom observed in both ADHD and ASD. Whilst in ADHD 
impulsivity constitutes a core symptom, in ASD it may be explained as a result of previously 
experienced high levels of stress caused by, e.g., involuntary disruption to familiar patterns of 
behaviour or routine sequences of events. Difficulties at an interpersonal level of social 
interaction can be present in both ADHD and ASD, in the case of ADHD in the form of 
increased levels of impulsivity and attention deficits, in ASD through impaired cognitive 
empathy and social intuition. ASD may also lead to increased physical activity (such as 
rocking and shaking) which, as stereotypical and repetitive behaviour, may erroneously be 
interpreted as symptoms of hyperactivity attributable to ADHD. Sensory over-responsivity 
can be symptomatic of ADHD as well as ASD (in the case of ASD hyposensitivity is equally 
possible), whilst difficulties with motor coordination are further symptoms associated with 
both disorders (Roy et al. 2013; Lenhardt et al. 2013). An overview of symptoms particular to 
ASD and/or ADHD is provided in Table 2. Phenomenologically, ASD is distinguished from 
ADHD by the following symptoms (cf. Lehnhardt et al. 2013): 
 
a) More severe problems at social and emotional interactional levels 
b) More severely impaired verbal and non-verbal communication 
c) Stereotypic or repetitive/ritualistic behaviours 
d) Obsessive adherence to routines and rituals 
e) Highly specific, fixated areas of interest, unusual in level of intensity or specificity of 
contents 
f) Detail-focused perceptual processing 
g) Compared to ADHD, in ADS more rarely observed higher levels of disorganisation 
as well as flightiness of thought and action 
 
3.1.3. Comorbidity 
In diagnosing ADHD or autism it is important to allow for the possibility that both these 
disorders may be comorbid, a fact which DSM-5 recognises. In 30-40% of adult ASD 
patients, diagnostic criteria for ADHD are fulfilled also (Hallerbäck et al. 2014; Rydén and 
Bejerot 2008; Rybakowski et al. 2014; Stahlberg et al. 2004). Amongst adult patients with a 
first-time ADHD diagnosis, too, a sub-group of patients is identified with comorbid ASD. In 
15% of patients diagnosed with ADHD, Roy et al. (2013) found a comorbid occurrence of 
Asperger‟s syndrome. From a neurobiological viewpoint there clearly appear to be certain 
shared traits, although research findings in this area remain as yet vague and inconclusive 
(Gargaro et al. 2011). 
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Table 2. Symptoms in ADHD and Autism 
 
Symptoms ADHD ASD 
 present? reason present? reason 
Deficits in 
social 
interaction 
 Might be present in 
ADHD due to 
impatience, 
attentional problems, 
impulsivity. Empathy 
might be constrained 
by attentional 
problems.  
 Core symptom of ASD 
 
Impaired cognitive 
empathy/Theory of 
Mind, deficits in non-
verbal communication 
and socio-emotional 
interaction.  
Repetitive or 
stereotypic 
behaviour  
X   Core symptoms of 
Autism  
Might be misinterpreted 
as ADHD symptoms. 
Routines or 
rituals  
X   Core symptom of ASD 
Special interests   Possibly hyper-
focusing on high-
interest tasks 
 Core symptom of ASD  
Highly restricted 
interests, that are 
abnormal in intensity or 
focus.  
Sensoric hypo- 
or 
hypersensitivity 
 Heightened 
sensitivity, e.g., 
towards sounds, due 
to increased 
distractibility.  
 Lack of/increased 
sensitivity to sensory 
stimuli such as sounds, 
touch, pain, light. 
 
Attentional 
problems 
 Core symptom of 
ADHD 
 
Distractibility, 
especially due to 
external cues  
 Low flexibility when 
shifting attention, 
heightened distractibility 
due to sensory stimuli 
and stress intolerance.  
Hyperactivity  Core symptom of 
ADHD 
 Increased bodily 
movements in the 
context of repetitive or 
stereotypic behavior 
might be misinterpreted 
as ADHD-hyperactivity. 
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Table 2. (Continued) 
 
Symptoms ADHD ASD 
 present? reason present? reason 
Impulsivity  Core symptom of 
ADHD 
 Might occur in case of 
involuntary disruption of 
habitual courses of 
events. 
 
Deviation of the status 
quo might cause stress 
and anger, which appears 
as impulsive behaviour. 
Detail-
oriented 
perception  
X   Impairment of central 
coherence  
Motoric 
abnormalities  
 Motoric hyperactivity 
and clumsiness might 
be present. 
 
 Clumsiness might be 
present. 
: present; X: not present. 
 
A further debatable aspect is whether ADHD-like symptoms in autism cases do in effect 
point to comorbidity or whether they are, instead, indicative of, e.g., a specific subtype of 
ASD with ADHD-like symptoms (Sinzig et al. 2009). 
Various studies demonstrate that ASD and ADHD are highly heritable 
neurodevelopmental disorders. Around 80% of phenotypic variance is attributable to genetic 
factors (Lichtenstein et al. 2010; Taurines et al. 2012). Family studies with ADHD patients 
show a familial aggregation of ASD symptoms within ADHD families. Studies on twin pairs 
suggest that 50-70% of the covariance of ADHD and autism symptoms is attributable to 
common genetic factors (Rommelse et al. 2010; Taurines et al. 2012). However, despite this 
highly heritable component, ADHD and autism patients do not necessarily remain 
permanently afflicted, since the brain displays high levels of neural plasticity also in 
adulthood which, under the influence of appropriate treatment or particular environmental 
factors, can enable neurodevelopmental disturbances to be outgrown (Ehninger et al. 2008). 
So far, only scant research into the comorbidity between ASD and ADHD exists, with 
inconclusive results. Thus the question remains whether a comorbidity between ADHD and 
ASD is representative of an additive symptoms overlap between the two disorders, or, indeed, 
of a new distinct clinical condition. The former assumption finds support in the results of a 
meta-study, albeit limited to childhood cases (Berenguer-Forner et al. 2015), where a 
combined disorder shows a more severe clinical profile than that found in patients diagnosed 
with either ASD or ADHD only, which indicates a symptoms overlap between ASD and 
ADHD. Research by Nydén et al. (2010) contradicts these findings, however, where of the 
three patient groups investigated (ASD, ADHD, ASD + ADHD), it was the ADHD group 
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rather than the group with comorbid ASD + ADHD which emerged as the most severely 
affected. 
 
3.1.4. Neuropsychology 
ADHD and ASD are both characterised by deficits of executive function abilities. 
Executive functions comprise various mental operations such as switching focus of attention 
(set-switching), cognitive flexibility, initiation and choice of action, strategic action planning, 
self-monitoring and working knowledge (Leung et al. 2015). Such deficits result from 
dysfunctions in the frontostriatal circuit which impair goal-oriented behaviour (Gonzalez-
Gadea et al. 2013; Gargaro et al. 2011). Abnormalities in frontostriatal brain regions and 
biochemical imbalances are thus suspected at the root of observed behavioural deficits in 
ADHD and ASD, which would explain the similarities between these disorders (Gargaro et 
al. 2011). 
Differences in severity of symptoms become evident in so far as with autism, difficulties 
with cognitive flexibility and planning are most prominent, whilst the problem of impaired 
executive functioning tends to be absent (Gargaro et al. 2011; Ambery 2006). By contrast, an 
ADHD profile contains impaired executive functioning and working memory and not 
cognitive flexibility and planning as primary symptoms (Gargaro et al. 2011; Sinzig 2008). In 
the areas of social cognition and, in particular, Theory of Mind (ToM) the findings are 
contradictory. Some research points to impaired ToM in ASD patients, which appears less 
likely to be the case with ADHD (Gonzalez-Gadea et al. 2013; Lehnhardt et al. 2011). Other 
findings contradict this hypothesis (Nydén et al. 2010), albeit under caveat by those authors 
that a display of lack of empathy/affection in relation to ToM in the ASD group may have 
emerged as a result of flawed ToM test validity (Nydén et al. 2010). Further studies on ASD 
patients found deficits in visual memory functioning (Ambery et al. 2006), linguistic 
pragmatics and holistic perception (Lehnhardt et al. 2011). 
 
 
3.2. ADHD and Substance Use Disorder 
 
3.2.1. Prevalence 
Psychotropic substance use disorders as defined in ICD-10, or substance-related and 
additive disorders as defined in DSM-5, form a heterogeneous group with widely differing 
estimates for prevalence rates. The variability in these rates partly stems from the 
differentiated sub-typification of the disorders according to substance type and respective 
complications associated with its use (e.g., in ICD-10 acute intoxication, substance abuse, 
substance dependence). Such worldwide variability disallows establishing standardised, 
reliable estimates for global prevalence. Problems related to alcohol use, however, are 
relatively consistently regarded as being of particular importance in the context of ADHD and 
comorbid substance use disorder. Alcohol use disorder is a common disorder on a worldwide 
scale. In the United States, for example, its prevalence rate amongst adults aged 18 and above 
is estimated at 8.5% (12-month prevalence; APA 2013). For other substances, prevalence 
rates are considerably lower, e.g., for cannabinoids 1.5% and opioids 0.37% (APA 2013). In 
comparison with figures for prevalence rates for ADHD, only estimates for the prevalence of 
alcohol use are higher, while all other substance-related and additive disorders rank decidedly 
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lower. From a differential diagnostic viewpoint, however, consideration of disorders related 
to psychotropic substances is essential, particularly in view of ADHD and its potential 
comorbidity with such disorders, especially in the case of alcohol use. 
 
3.2.2. Differential Diagnosis 
There are several challenges involved in establishing a diagnosis for ADHD and 
comorbid substance use disorder (SUD). Firstly, there is an overlap between a number of 
symptoms common to both disorders, as illustrated in Table 3, which warrants careful 
consideration. In addition, a further diagnostic problem emerges from the fact that patients are 
often unable to recall substance-free periods, which renders their ability to differentiate 
between individual symptoms difficult, not least because ADHD-like symptoms present also 
during episodes of substance withdrawal and abstinence. A course of detoxification treatment 
can further contribute to enhanced manifestation of ADHD symptoms. Ideally, a precondition 
for an ADHD diagnosis should therefore, wherever possible, be a completed course of 
detoxification therapy followed by a supervised sustained period of abstinence of a 
recommended minimum of 1 month. Also Tuckman (2007) confirms that in cases of 
prolonged and complex substance abuse it can become diagnostically difficult to determine 
which type of disorder a set of particular symptoms is attributable to. It would therefore be 
sensible to prioritise treatment for substance disorder and subsequently, after a 5-month 
period of abstinence, conduct a renewed assessment of the patient for ADHD symptoms. 
However, the proposition to defer a firm ADHD diagnosis until such time as successful 
completion of a prolonged episode of supervised sustained abstinence is attained remains, in a 
clinical context, often unrealistic. A more pragmatic approach would be an attempt to identify 
those symptoms which were attributable to ADHD before the onset of substance use, for 
which purpose the gathering and evaluation of information from third parties may become 
necessary. 
 
3.2.3. Comorbidity 
With the generally high rate of comorbidity in ADHD, comorbidity with psychotropic 
substance disorders is of particular interest. According to Wilens et al. (2003), untreated 
ADHD cases run a 1.5-fold increased risk of proceeding to develop substance abuse-related 
disorders. The significance of the combination of ADHD with substance disorders has been 
conclusively confirmed in a series of empirical studies. As well as other substances, this is 
especially the case in relation to alcohol. 
Prevalence rates for comorbidity of ADHD with SUD are high, although the literature 
fails to present an entirely coherent picture. The National Comorbidity Survey Replication 
(NCS-R, cited in Mariani and Levin 2007) established a rate of prevalence for ADHD of 
44%. Of the cases diagnosed with ADHD, 15.2% additionally met criteria for a SUD 
diagnosis; conversely, 10.8% of patients diagnosed with SUD were additionally found to be 
suffering from ADHD. In clinical treatment settings, these figures appear to be markedly 
higher. Torrens et al. (2012) identified 33% of ADHD patients as suffering from SUD, while 
17-50% of SUD patients were diagnosed with comorbid ADHD. 
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Table 3. Clinical characteristics and outcome of patients with ADHD and SUD in 
relation to patients with ADHD or SUD 
 
Earlier onset of substance use and abuse 
More likely to initiate smoking and at a younger age, as well as become 
dependent on nicotine, and have more difficulty quitting smoking 
More severity and chronicity of the addictive disorder 
A more severe course of illness of ADHD 
Less likely to achieve abstinence  
Higher rates of poly-substance abuse  
Increased psychiatric comorbidity 
Lower treatment retention rates 
 (See Martinez-Raga et al. 2013) 
 
In a clinical context, an analysis and explanation of the mechanics of the association 
between ADHD and comorbid SUD is highly desirable. Figure 1 contains an example which 
serves to illustrate a possible scenario for the development of the association between these 
two disorders over time. 
ADHD is essentially a psychiatric disorder triggered by neurobiological factors, the 
symptoms of which become of relevance on their first manifestation in childhood (phase 1). 
ADHD symptoms, which frequently fail to be diagnosed at their earliest stage of onset 
can, through aggregation of deficits over time (phase 2), result in a depressive episode (phase 
3) during which a patient may resort to inadequate self-help and coping strategies in the form 
of substance use (phase 4). Such self-medication assumes particular significance for the adult 
patient, which is characteristic of that stage in the temporal developmental trajectory of 
ADHD. 
Inattention is one of the symptoms which persist into adulthood, while childhood 
impulsivity and hyperactivity tend to decline with increasing age. In many adult patients, 
impulsivity and hyperactivity are replaced by increasing inner tension which can act as the 
catalyst for self-medication in the form of substance use. This is merely a simple, yet 
sufficiently plausible scenario and, particularly in a clinical setting, representative of an often 
observed combination of overall symptoms. It is important to remember that the sequences of 
symptoms development described here as phases 3 and 4 can, of course, occur in reverse 
order as well. 
A further point is that this course of development is likely to manifest only in cases where 
ADHD failed to be recognised at an early stage of onset. Experience indicates, however, that 
in the context of adult psychiatry in special outpatient units, up to 90% of recorded cases were 
never previously assessed for or diagnosed with ADHD and had, correspondingly, never 
received appropriate treatment. 
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Figure 1. Example of the development of comorbidity in adult ADHD. 
Studies on childhood patients (e.g., Biedermann et al. 2000) indicate that failure to 
recognise ADHD symptoms in children can already during childhood lead to severe 
complications, one of which is an especially early onset of alcohol use. According to 
Tuckman (2007), stimulant therapy for ADHD in children exercises a protective effect in 
relation to later substance abuse. The reasons for this are twofold in that, firstly, patients who 
benefited from stimulant therapy to treat their childhood ADHD are in a better position to 
master their adult lives and, secondly, as a result they are less likely to resort to self-help 
strategies in the form of self-medication and psychoactive substance use. 
The various problems arising from a combination of ADHD and comorbid substance 
disorder, and their respective outcome variables, are summarised in Table 4. This overview 
demonstrates the significance of the various consequences resulting from this combination of 
disorders and the need for their inclusion in any considerations regarding possible courses of 
treatment. 
It further emphasises the clearly enhanced complexity of the association between ADHD 
and substance disorder and the concomitant high demands put upon the clinician in the 
management and treatment of these. 
In the context of establishing a clinical diagnosis, the following two possible scenarios 
are of relevance: 
 
 a patient with suspected ADHD seeks clinical assessment with an additional 
requirement for screening for SUD; 
 a patient suffering from SUD seeks treatment or, alternatively, is already in receipt of 
treatment, and has an additional requirement for screening for ADHD. 
 
Given the high rate of comorbidity of ADHD and SUD, and the fact that ADHD 
symptoms manifest prior to substance use, a timely and accurate ADHD diagnosis is essential 
in order to initiate prompt treatment and prevent adverse developments. ADHD patients have 
a predisposition for early development of more severe instances of substance abuse and 
dependence disorders. Cases of alcohol dependence are often also accompanied by risk-
related patterns and practices of substance use as well as a progression from legal to illegal 
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drug use. In all treatment settings where clinicians are confronted with potential ADHD cases, 
diagnostic precision and accuracy are of the essence. 
 
Table 4. Symptomatology: overlapping aspects between ADHD and addiction 
 
Components 
 
psychopathology clinical fatures 
Substance effect Acute intoxication or 
withdrawal symptoms  
Agitation, mood instability, 
anxiety, intolerance, prone to 
frustration, restlessness, 
impulsivity, concentration, and 
memory difficulties 
Addictive process Craving and loss of 
control 
Impulsivity, poor decision making, 
planning difficulties, mood 
instability, dysphoria, anxiety, 
continued substance use in spite of 
adverse consequences 
 
Preexisting 
neuropsychological 
conditions 
Deficits in executive 
functioning 
Impulsivity, risk-taking behavior, 
inattention, inability to inhibit 
responses 
Psychiatric comorbidity Mood and anxiety 
disorders, 
borderline and antisocial 
personality disorders 
 
Mood instability, anxiety, 
impulsivity, risk-taking behavior, 
intolerance to frustration 
(see Fatseas et al. 2012). 
 
It is imperative that patients diagnosed with ADHD are also screened for potential 
psychotropic substance disorders, for which a number of relevant screening instruments for 
ADHD as well as substance disorders are now available (e.g., Stieglitz and Raes 2015). 
The importance of accurate diagnosis has been confirmed in various studies. McAweeny 
et al. (2010) for example point out that treatment programmes for psychotropic disorders 
often overlook ADHD symptoms. In their own study, McAweeny et al. further found that a 
mere 3% of the clinical medical histories of patients from his study contained an ADHD 
diagnosis which, however, in a comprehensive follow-up study, rose to an astonishing 44%. 
From these findings it may be concluded that there is, indeed, a pronounced risk that against 
the background of psychotropic substance use ADHD symptoms remain underdiagnosed, 
which is largely on account of the fact that the initial clinical picture obtained is more 
strongly defined by the symptoms relating to psychotropic substance use than it is by ADHD 
symptoms. According to Bukstein (2011) the cause for this often lies in SUD patients failing 
to be screened for ADHD symptoms, and in diagnoses for disorders such as depression and 
hypomania which serve to further obfuscate the path to an ADHD diagnosis. As a result, van 
der Glind et al. (2013) postulate that in view of the high prevalence of adult ADHD, all 
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patients seeking treatment for SUD should be screened for ADHD and, in the case of a 
confirmed diagnosis, receive treatment for ADHD in order to prevent unfavourable treatment 
outcomes which, as outlined in the literature, would otherwise be likely to follow. 
 
3.2.4. Neuropsychology 
In a clinical context, the various facets of executive functioning (EF) play an important 
role in ADHD (cf. also other sections). EF-related impairments such as organisation deficits 
are often the reason behind a first assessment for ADHD and are at the root of long-term 
problems that patients encounter in the workplace and in social relationships. Also of central 
significance are attention deficit related problems. In contrast to hyperactivity and 
impulsivity, these represent the most persistent phenomena over time in so far as hyper-
activity and impulsivity tend to decline with age, while attention deficits persist. In addition, 
patients repeatedly mention numerous problems related to various memory processes such as 
general forgetfulness, forgetfulness in respect of received instructions, or forgetfulness in 
connection with task fulfilment requirements. Various meta-analyses confirm, in comparison 
with healthy controls, the presence of such deficits in ADHD patients (e.g., Schoechlin and 
Engel 2005). 
A similar picture emerges in patients with psychotropic substance use disorders. It has 
been demonstrated repeatedly that one to two thirds of persons with chronic alcohol or other 
psychoactive substance use disorders show deficits in various cognitive areas such as 
memory, attention, executive functions, information processing and other cognitive abilities 
(Scheurich and Brokate 2009; Verdejo-García et al. 2004). As may be expected, most 
publications available on psychotropic substance disorders relate to alcohol use. As a result, 
the majority of studies on alcohol-dependent persons found memory tests to show either no 
impairments, or impairments of medium severity only. With regard to executive functions, 
most diagnoses in alcohol-dependent patients indicated impairment or limitations to at least 
parts of the areas of executive functions. Studies also found, however, that in some cases, 
after a given period of abstinence, it was possible for patients to go into remission 
(Pawlikoswki and Brand 2013). 
In relation to other substances, Verdejo-García et al. (2004) showed that chronic heroin 
use leads to various cognitive impairments in the areas of executive functions (e.g., working 
memory), attention, impulse control and decision making behaviour. As concerns use of 
cocaine, their study contains few conclusive findings. They identified especially the areas of 
short-term memory, attention, inhibition control, abstract reasoning and psychomotor activity 
as being affected by chronic cocaine use. Concerning cannabis use, the available data remains 
inconclusive as well. Initial studies indicate minor impairments at the levels of executive 
functions, memory and attention. Whilst with most substances only chronic use leads to 
impairments, studies have shown that with MDMA (Ecstasy) cognitive impairments in the 
areas of memory and working memory become already evident with mere sporadic use. 
Further extensive studies are needed in order to arrive at conclusive results, yet it clearly 
transpires already now that the neurotoxicity of the various substances appears to lead to 
specific neuropsychological deficits, and that chronic substance use impairs cognitive 
functional abilities (Pawlikowski and Brand 2013). In summary, it is evident that both SUD 
and ADHD show impairments in various neuropsychological relevant domains which, in 
parts, share certain similarities (e.g., affected executive functions and, to some degree, 
memory). 
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On the one hand, the presence of neuropsychological symptoms underlines the relevance. 
On the other hand, however, on account of the similarities between the symptoms of ADHD 
and SUD, the application of neuropsychological assessment procedures for differential 
diagnostic purposes is called into question. 
 
 
3.3. Schizophrenia 
 
3.3.1. Prevalence 
Compared to ADHD, the prevalence of schizophrenia is considerably lower. Lifespan 
prevalence rates are estimated at between 0.5% and 1.6%. The onset of schizophrenia is 
believed to occur between the ages of 15 – 35, with two thirds of patients showing first 
symptoms before the age of 30. According to recent studies, however, first indications of a 
possible onset of the disorder may show at a still younger age. Men tend to become affected 
three to four years earlier than women. The gender ratio between male and female patients is 
roughly even. 
 
3.3.2. Differential Diagnosis 
In daily clinical practice, the differential diagnosis for either ADHD or schizophrenia 
does not generally pose a significant challenge, although schizophrenia does explicitly feature 
as an exclusion criterion in DSM-5 (APA 2013) („symptoms do not occur exclusively during 
the course of schizophrenia,” p. 60). There exist common features between both disorders, 
which, however, do not stand up to a more thorough exploration according to diagnostic 
criteria. 
Initially, on first comparison of the two symptom areas, no overlap is recognisable (cf. 
Table 5). Whilst the symptoms of schizophrenia are primarily those of the classic 
psychopathological type such as delusions, hallucinations, ego disorders and thought 
disorders, the symptoms of ADHD tend to be more in the emotional and behavioural areas. 
This greatly simplifies the process of medical history taking. 
 
Table 5. Symptomatology of ADHD and Schizophrenia 
 
 ADHD Schizophrenia 
Core symptoms (diagnostic 
criteria) 
Inattention  
 Hyperactivity  
 Impulsivity  
  Ego-disorders 
  Delusions 
  Hallucinations 
  Thought disoders 
  Catatonic behavior 
  Negative Symptoms 
Associated features 
(examples) 
Inner restlesness Cognitive deficits like memory 
problems, inattention 
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Problems are more likely to arise at the level of associated features of schizophrenia, 
where a symptoms overlap with ADHD becomes possible in the context of symptoms like 
attention deficits, inner tension and disorganised behaviour. Studies on the subject of ADHD 
and comorbid schizophrenia are rare, as the validity of the concept of comorbidity between 
the two disorders remains disputed. 
 
3.3.3. Comorbidity 
Brown‟s reader (2009), for instance, contains no section on ADHD and schizophrenia, 
and the term schizophrenia does not feature in the index. There is a small number of studies, 
however, which do point towards the existence of a possible comorbidity between 
schizophrenia and ADHD. Ross et al. (2006) conducted research focused on children and 
adolescents aged 4-15. In their sample of 82 schizophrenia patients, 84% also tested positive 
for ADHD. Unenge Hallerbäck et al. (2014), in their sample of 41 adult patients with 
schizophrenia, diagnosed 10% with additional ADHD. Differences in diagnostic approaches 
and methods in areas such as conceptual problems (e.g., analysis and evaluation) prevent 
conclusive answers in respect of comorbidity. However, there seems to be agreement that 
treatment of a potential comorbidity between these two disorders requires approaches to their 
management and treatment to be adapted accordingly. Thus, the treatment of ADHD 
symptoms with methylphenidate in the presence of potential comorbid schizophrenia is 
generally regarded as contraindicative (cf. Kraemer et al. 2010). 
 
3.3.4. Neuropsychology 
The perception of neuropsychological deficits in schizophrenic patients has been 
modified over the past few years. Whilst cognitive deficits were initially regarded as an 
epiphenomenon or associated with long-term pharmacological treatment, they are now 
considered as core deficits of the disorder, as endophenotypes of schizophrenic psychosis, and 
as such count as mediating factors between genotype and phenotype of the disorder (Pflüger 
et al. 2013). 
Neuropsychological deficits are a frequent and characteristic feature of schizophrenic 
disorders. They are generally reliably assessed, as there is now an almost endless array of 
studies available on the various aspects of cognitive performance in schizophrenic patients. 
Despite considerable heterogeneity in methodological approaches adopted in individual 
studies, and heterogeneity also in type and extent of cognitive deficits present in patient 
populations, the findings of existing meta-analyses are surprisingly consistant (Exner and 
Lincoln 2012). Across the whole spectrum of functional areas included in a variety of 
assessment instruments deployed for diagnostic purposes, the performance levels of 
schizophrenic patients are found to be roughly one standard deviation below the mean of that 
of healthy controls. It is questionable whether, against the background of such globally 
impaired cognitive functioning, it remains possible to identify areas which are selectively 
more heavily impaired. The discussion centres around whether, for example, verbal episodic 
memory, executive functions, and cognitive processing and encoding speeds respectively are 
especially heavily affected, and to what extent attention-related sub-areas such as those of 
selective, shared or sustained attention may be impaired (Exner and Lincoln 2012). Schaefer 
et al. (2013) have confirmed findings from past meta-analyses in a recent meta-analysis of 
their own. They were able to demonstrate that patients with schizophrenia showed 
considerably lower values than controls in all cognitive tests and all areas of cognitive 
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functioning (grand mean effect size, g = -1.03). The situation is thus of similar complexity to 
that of ADHD, in which partly similar symptoms present, with the result that 
neuropsychological procedures are likely to be less suited for differential diagnostic purposes. 
Direct comparisons between the two disorders remain, however, rare. Gansner et al. (in 
preparation) compared the neuropsychological performance of 233 ADHD patients against 
the performance of 127 ARMS (at-risk mental state) patients. In the Continuous Performance 
Test and the California Verbal Learning Test, the ADHD group performed significantly 
worse than ARMS subjects. In the Tower of Hanoi task, ARMS patients were markedly 
slower but made fewer mistakes than ADHD subjects. These results indicate that patients 
with ADHD perform considerably worse in tasks of executive functions, sustained attention 
and verbal learning and memory than ARMS individuals. 
 
 
3.4. ADHD and Affective Disorders 
 
3.4.1. Prevalence 
Like ADHD, affective disorders, too, count amongst the most common psychiatric 
disorders (Kessler et al. 2009) and with their lifetime prevalence rate of 12% slightly exceed 
that of ADHD, which is estimated at a figure of 7%. Depending on the subtype of disorder, 
prevalence rates for affective disorders vary between 7.6 and 17.9%. In particular, the 
following lifespan rates of prevalence emerge: depressive disorders 4.0-10.0%; bipolar 
disorders 0.8-1.5% (for an overview, see Kessler et al. 2009). In industrialised countries rates 
for depressive disorders are higher than in the developing world, with women being almost 
twice as likely to be affected than men (1.7:1) (Kessler et al. 1993; Kessler et al. 2009). In 
contrast to ADHD, no such marked gender differences are recorded with bipolar disorders 
(Merikangas et al. 2007). 
 
3.4.2. Differential diagnosis 
Against the background of a high symptom overlap between affective disorders, in 
particular bipolar disorders, and adult ADHD, diagnostic differentiation between the two 
types of disorders in each instance of ADHD assessment is essential. Establishing a 
differential diagnosis between the symptoms of these two disorders remains, however, 
challenging, as both show a large overlap between at times barely distinguishable symptoms 
(see Table 6). A differentiation based on symptom areas and level of symptom severity 
becomes therefore only partly realisable. 
Only certain symptom areas are involved in a symptoms overlap between depressive 
disorders and ADHD (in particular attention-deficit disorders and, to some extent, inner 
restlessness). As a result, symptoms such as severe depressive mood swings and profound 
loss of interest and inner drive, symptomatic of a depressive disorder, remain relatively 
clearly distinguishable from persistent hyperactivity and impulsivity found in ADHD (Kooij 
et al. 2012). By contrast, differentiation between ADHD and bipolar disorders with 
manic/hypomanic episodes proves more difficult, as these disorders show an overlap in 
various symptom areas. A differentiation of disorders on the basis of a differentiation between 
their symptoms only proves thus difficult (Asherson et al. 2014; Perroud et al. 2014; Skirrow 
et al. 2012). 
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However, with bipolar disorders and ADHD, too, specific characteristics are present in 
their respective symptoms which enable differentiation between them: whilst a reduced need 
for sleep, the presence of additional psychotic symptoms, inflated self-esteem and a 
subjective feeling of racing thoughts are specific to bipolar disorders, in ADHD low self-
esteem and an increased distractibility are often dominant (Asherson et al. 2014; Perroud et 
al. 2014). 
 
Table 6. Symptoms of ADHD, Major Depression and Bipolar I/II Disorder 
 according to DSM-5 
 
ADHD Major depressive disorder 
(criteria of a major 
depressive episode) 
Bipolar I/II disorder (criteria of a 
(hypo-) manic episode) 
Inattention 
 Fails to give close attention 
to details/makes careless 
mistakes 
 Difficulty sustaining 
attention  
 Does not seem to listen 
when spoken to directly 
 Not follow through on 
instructions and fails to 
finish schoolwork, chores, 
or duties in the workspace 
 Difficulty organizating tasks 
and activities 
 Avoids, dislikes, or is 
reluctant to engage in tasks 
that require sustained 
mental effort 
 Loses things necessary for 
tasks or activities 
 Easily distracted by 
extraneous stimuli 
 Forgetful in daily activities 
 
 
 
A-criteria: 
8. Diminished ability to 
think or concentrate, or 
indecisiveness 
 
 
 
B-criteria: 
4. Flight of ideas or  
 subjective experience  
 that thoughts are  
 racing 
 
 
 
 
 
 
 
 
 
 
 
 
5. Distractibility 
 
 
Hyperactivity and impulsivity 
 Fidgets with or taps hands 
or feet or squirms in seat 
 Leaves seat in situations 
when remaining seated is 
expected 
 Runs about or climbs in 
situations where it is 
inappropiate 
 Unable to play or engage in 
leisure activities quietly 
 “On the go”, acting as if 
“driven by a motor” 
 Talks excessively 
 
5. Psychomotor agitation or  
 retardation nearly every day 
 
6. Increase in goal- 
 directed activity or  
 psychomotor agitation 
 
 
 
 
 
 
 
 
 
 
3. More talkaktive than  
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ADHD Major depressive disorder 
(criteria of a major 
depressive episode) 
Bipolar I/II disorder (criteria of a 
(hypo-) manic episode) 
 Blurts out an answer before 
question has been 
completed 
 Difficulty waiting his or her 
turn 
 Interrupts or intrudes on 
others 
 usual or pressure to  
 keep talking 
 
 
Additional symptoms 
 affective lability 
 Stress intolerance 
 Outbursts of rage 
 Sleeping disorders 
 
 Low self-esteem/low self-
concept 
 
1. Depressed mood most of 
the day 
 
4. Insomnia or hypersomnia  
 
7. feeling of worthlessness or  
 excessive or inappropriate  
 guilt  
  
2. Markedly diminished  
 interest or pleasure in  
 activities 
 
3. Significant weight loss  
 
 
 
 
2. Decreased need to sleep 
 
1. Inflated self-esteem or  
 grandiosity 
 
 
7. Excessive involvement  
 in activities that have a  
 high potential for  
 painful consequences 
 when not dieting or weight 
gain or decrease or increase 
in appetite 
6. Fatigue or loss of energy 
9. Recurrent thoughts of 
death, suicidal ideation, or a  
 suicide attempt 
 
Progress 
 Several symptoms were 
present prior to age 12 years 
 
 Chronic progress: symptoms 
remain after onset 
(fluctuations in the severity 
of symptoms possible) 
 
 Onset in childhood and 
adulthood possible 
 Incidence appears to 
peak in the 20s 
 Five or more symptoms 
have been present 
during the same 2-
week-period  
 Change from previous 
functioning within a 
period  
 
 Onset in childhood and 
adulthood possible 
 Mean age at onset of the first 
episode is approximately 18 
years 
 Distinct periods of abnormally 
and persistently elevated, 
expansive, or irritable mood 
and abnormally and 
persistently increased goal-
directed activity or energy, 
lasting at least 4 days/1 week 
Note. Modified criteria of DSM-5 (APA; 2013). 
 
In addition, consideration of temporal progression should also always form part of the 
differential diagnostic process: while affective disorders progress through clearly definable 
episodes of pronounced manifestation of symptoms, ADHD is a chronic developmental 
disorder with persistent symptoms (Asherson et al. 2014; Skirrow et al. 2012). Various 
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researchers regard careful and precise application of this criterion in the differential 
diagnostic process as imperative in order to enable differentiation between the symptoms of 
these disorders (e.g., Asherson et al. 2014; Perroud et al. 2014; Skirrow et al. 2012). 
Differential diagnostic assessment should thus occur during the course of a euthymic 
phase (i.e., an interval of a balanced state of mood between manic/depressive phases). This 
approach should serve to diminish the potential for confusion and lead to more effective 
discrimination between the two types of disorder. 
 
3.4.3. Comorbidity 
Consideration must be given not only to the need for clear clinical differentiation 
between affective disorders and ADHD but also to the potential for concurrence of affective 
disorders with ADHD. The prevalence rates for comorbidity between ADHD and an affective 
disorder lie between 19% and 37% (Stieglitz et al. 2012), whereby comorbidity with 
dysthymia is particularly frequent. Different studies put prevalence rates for comorbidity of 
ADHD with depressive disorders at between 9.7% and 40.7% (Biedermann et al. 2008; 
Kessler et al. 2006; Pineiro-Dieguez et al. 2014). Still larger variability in comorbidity rates 
appear to exist between ADHD and bipolar disorders. In their review, Frías et al. (2015) 
report comorbidity rates of between 4% and 94% (with a mean value of 48%), depending on 
respective studies. They attribute such variability inter alia to starkly differing random 
sampling methodology adopted in the studies reviewed (e.g., outpatient vs. inpatient 
sampling; sampling of childhood onset bipolar disorder vs. adult bipolar disorder). According 
to Wilens et al. (2003), around 10% of ADHD patients develop an additional bipolar disorder, 
and 15% of patients with a bipolar disorder also suffer from ADHD. Later studies, too, yield 
equally inconsistent results. Di Nicola et al. (2014), for example, recorded in persons with 
bipolar disorders a prevalence rate of comorbidity between ADHD and bipolar disorders of 
15.7%, and between ADHD and depressive disorders of 7.5%; whereas Pineiro-Dieguez et al. 
(2014) found in persons with ADHD a comorbidity rate between depressive disorders and 
ADHD of 9.7% and between bipolar disorders and ADHD of 2.5%. Studies further 
demonstrate a correlation between ADHD and comorbid bipolar disorders and an early onset 
of the bipolar disorder, a higher number of depressive and mixed episodes, fewer 
asymptomatic periods, worse outcomes and increased negative reaction to treatment 
(Karaahmet et al. 2013; Tamam et al. 2008). Furthermore, it has been shown that also the 
severity of ADHD symptoms during manic/hypomanic and mixed episodes becomes 
enhanced. Also, an increased number of comorbid disorders, in particular anxiety, substance 
use and borderline personality disorders, were found in patients suffering from both ADHD 
and bipolar disorders. 
 
3.4.4. Neuropsychology 
From a neuropsychological viewpoint, symptoms of all three disorders contain impaired 
executive functions which in depressive disorders remain largely restricted to affective 
episodes, whilst in ADHD they are of a chronic nature. Attention deficit problems in patients 
with bipolar disorders were, however, also found outside acute phases (for an overview see 
Hegerl et al. 2010). 
Patients with ADHD as well as patients with bipolar disorders show similar cognitive 
impairments in various areas. In both groups, visual and verbal working memory and 
response inhibition are affected, while control and planning deficits are more associated with 
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bipolar disorders, and deficits in spatial working memory and language fluency are reported 
to be more specific to ADHD. Different studies arrive at partly contradictory results as to 
which areas of impairment are more likely attributable to which disorder, resulting in a 
disparate picture which serves to complicate rather than facilitate the application of 
neurobiological testing procedures in the differentiation between the two disorders (Skirrow 
et al. 2012). Over the past few years, research has begun to focus on the neuropathology of 
ADHD and bipolar disorders. Under discussion are, amongst other issues, a potential genetic, 
neuropsychological and brain structural overlap (Hegerl et al. 2010; Di Nicola et al. 2014; 
Skirrow et al. 2012). Present findings and results appear here, too, to project a rather 
heterogeneous picture; while some findings demonstrate agreement on neural correlates, 
others indicate differing neural correlates for the two disorders (for an overview, see Hegerl et 
al. 2010; Skirrow et al. 2012). Currently, depending on the type of disorder, an increasing 
number of findings seem to speak for the application of imaging technology in the detection 
of symptoms in different anatomical and functional regions of the brain (Biederman et al. 
2008; Brown et al. 2012; Faraone et al. 2001). These findings lead to the conclusion that the 
pathogenesis of each of the two types of disorder tends to develop independently of each 
other. Nevertheless, above-average prevalence rates of comorbidity point at least partly to a 
common pathogenesis of the disorders. 
 
 
3.5. ADHD and Anxiety Disorders 
 
3.5.1. Prevalence 
ADHD affects roughly 4-12% of school-age children and 2-6% of adults amongst the 
normal population. This incidence rates have found to be stable across different cultures (e.g., 
White and Shah 2006). While in certain cultures or occupations, a predisposition towards 
ADHD might not affect the individuals a lot and it might even be regarded as a gift, it usually 
clashes with the values and way of life in Western cultures. This is why many people with 
ADHD develop comorbid disorders over the life time, such as depression, low self-esteem 
and, last but not least, anxiety disorders. 
The prevalence of anxiety disorders in the normal population lies between 5 to 15%, 
whereby the life time prevalence of the group of the disorder can be as high as 25%. 
Furthermore, they tend to be highly comorbid with each other as well as with other 
psychiatric disorders. In their review, Somers et al. (2006) calculated the pooled 1-year and 
lifetime prevalence rates for all anxiety disorders being between 10.6% and 16.6%, with an 
average life-time prevalence rate for panic disorder of 3.8%, agoraphobia of 3.4%, social 
phobia of 7.8%, specific phobia of 10.1%, Obsessive Compulsive Disorders (OCD) of 0.9%, 
General Anxiety Disorder (GAD) of 2.3% (Bijl et al. 1998, with a total life-time anxiety rate 
of 19.3%), and Post-Traumatic Stress Disorder (PTSD) of 7.8% (Kessler et al. 1994, with a 
total life-time anxiety rate of 24.9%). 
 
3.5.2. Differential Diagnostics 
The differentiation between ADHD and other disorders is not easy, as many psychiatric 
disorders result in symptoms of inattention, hyperactivity and/or impulsivity. A general rule 
of thumb in differentiating between ADHD and anxiety disorders are persistent fears and 
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worries accompanied by somatic symptoms in people with anxiety disorders, whereas ADHD 
subjects tend to be anxious in relation to specific academic or social situations in which they 
fear failure due to inattention or impulsivity (Quintana et al. 2007). More accurate methods 
include EEG measures, neuropsychological tests and highly elaborated psychometric 
assessment instruments. Table 7 provides an overview for discriminating between ADHD and 
anxiety disorders. 
Turning to Electroencephalography (EEG) the most accurate measure in order to 
discriminate between ADHD populations and normal controls is the EEG theta-beta ratio, 
with a specificity as high as 94-98% (Monastra et al. 2001). Barry et al. (2003) carved out 
three different EEG patterns in people with ADHD: a hypoarousal group, showing increased 
theta waves, but lowered beta waves; a hyperarousal group, with increased beta waves, but 
decreased theta waves; and, the biggest group with increased delta and theta waves, but 
lowered alpha and beta waves. 
Although seemingly obvious, these three EEG groups have been found to not correspond 
to the three subtypes of ADHD. Rather, the three subtypes differ in the strengths of the EEG 
abnormalities, with the combined type showing the highest degree of abnormality, followed 
by the hyperactive type; the inattentive type displayed the lowest degree of abnormal EEG 
patterns. In anxiety disorders, EEG abnormalities highly differ from those in ADHD subjects. 
For panic disorders, for example, a low alpha wave with normally functioning beta, theta and 
delta waves seems to be typical (Enoch et al. 1995). In OCD patients, beta waves tend to be 
increased rather than decreased as in ADHD individuals (Hammond 2005). Moreover, 
anxious individuals tend to show a greater relative right frontal electroencephalographic 
(EEG) activity compared to normal controls (Blackhart et al. 2006). In contrast, an over-
connectivity between the two hemispheres has been observed in ADHD (Murias et al. 2006). 
Often, ADHD subjects clearly show higher cerebellar and basal ganglia dysfunctions than 
subjects with anxiety disorders. 
Besides, there exists a raw of assessment instruments for diagnosing ADHD. Hereby it is 
essential not only to examine ADHD specific symptoms in ADHD diagnostic procedures, but 
to ask for typical symptoms of other disorders, as well, for avoiding false-positives. In regards 
to anxiety disorders, one could include screening instruments such as the BAI Beck Anxiety 
Inventory (Beck and Steer 1993), the M.I.N.I. Mini International Neuropsychiatric Interview 
(Sheehan et al. 1998) or the K-SADS-PL Supplements for Anxiety Disorders and Affective 
Disorders (Quintana et al. 2007). Sensitivity and specificity for anxiety disorders have been 
found to be good or very good for the M.I.N.I., besides for generalized anxiety disorders; in 
the latter case, one might use the GAD-7 Generalized Anxiety Disorder (7 items) instead, 
with high sensitivity (89%) and specificity (82%) (Spitzer et al. 2007). For further 
investigation of all anxiety disorders, which is not too time-consuming, the anxiety section of 
the SCID I (structured clinical interview for DSM-IV, axis I) might be suitable, with high 
sensitivity and specificity. 
 
3.5.3. Comorbidity 
Schatz and Rostain (2006) speak of a 25% comorbidity rate of ADHD with anxiety 
disorder; hence, every fourth adult presenting with ADHD in our psychotherapeutic office is 
likely to have some kind of comorbid anxiety disorder. Anxiety disorders in general have 
been found to affect ADHD symptoms in specific ways, whereby: 
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Table 7. Differential features between ADHD and Anxiety disorders 
 
ADHD Anxiety disorders 
 High impulsivity and low cognitive 
inhibition, esp. response inhibition 
 
 dysfunctional social behaviour: disrupted 
family and peer relationships 
 
 lack of planning and control of cognitive 
processes 
 disorganized general cognition as a result of 
lack of executive functioning (independent of 
external cues) 
 poor executive regulatory control 
 lower sustained attention 
 strong preference for immediate rather than 
future rewards 
 disruptive and inappropriate behaviour 
 anxious in relation to specific academic or 
social situations in which they fear failure due 
to inattention or impulsivity 
 deficits in monitoring attentional resources 
 lower error monitoring; lower interference 
control 
 
 attentional disengagement 
 spontaneous, impulsive decision making; 
delay aversion 
 emotional dysregulation, sudden mood 
swings, high moment-to-moment fluctuations 
 lower inhibition of a pre-potent response 
 higher-than-average abilities in creativity 
 increased cerebellar dysfunction 
 Impaired basal ganglia 
higher motor speed, higher capability of 
motor fluency and accuracy and increased 
choreoform and athetoid movements 
 
 
 an impaired nucleus accumbens-striatum-
orbitofrontal cortex circuit 
 
 
 
 
 dopamine dysregulation 
 BAS system higher activated -> greater 
impulsivity and risk-seeking behaviour 
 general memory malfunctions due to storage 
and retrieval problems. 
 problems with working memory and 
general cognition other than 
cognitive inhibition 
 socially phobics tend to focus on 
themselves and worry about 
embarrassment 
 planning and attentional shifting 
normal; spatial recognition, working 
memory and motor initiation 
impaired (esp. OCD) 
 
 
 
 
 
 
 persistent fears and worries 
accompanied by somatic symptoms 
 
 
 no association between error 
monitoring and anxious behaviour 
 
 attentional hyper-focussing 
 slower decision making than normal 
controls 
 serotonine dysregulation, more 
permanent mood 
 
 
 
 
 lower verbal creativity in OCD than 
in normal control 
 
 spatial working memory and spatial 
recognition impaired, motor initiation 
and execution slower than in normal 
controls; 
 lower visuo-constructional 
functioning  
 impaired septo-hippocampal system, 
amygdala, hypothalamus and 
periaqueductal grey; especially 
hyper-activation of the 
hypothalamus–pituitary axis; 
 acetylcholine dysregulation 
 avoidance of novelty seeking 
 
 Panic disorder with/without 
agoraphobia, social phobia, OCD: 
impairments in episodic memory. 
See: Schatz and Rostain (2006); Quintana et al. (2007); Gupta and Kar (2010); Vance et al. (2006). 
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 impulsivity and response inhibition deficits are likely to decrease, 
 working memory deficits and other cognitive problems usually get worse. 
 
Therefore, although there is not a higher rate of anxiety amongst the inattentive subtype 
compared to the mixed or more hyperactive subtypes, anxiety does increase the symptoms in 
the inattentive subtype, rendering a tendency towards sluggish cognitive tempo even worse. 
This, in turn, feeds feelings of anxiety, insufficiency and depression, so that a vicious circle 
develops affecting many areas in life, which explains why comorbid anxiety in ADHD 
usually appears differently compared to more phobic types of anxiety seen in pure anxiety 
samples. 
 
3.5.4. Neuropsychology 
People with ADHD display specific deficits in monitoring attentional resources, which 
negatively influence response inhibition, error monitoring, attentional disengagement, 
decision making processes and emotion regulation (Gupta and Kar 2010).The core difficulty 
for ADHD patients has been proven to be sustained and selective attention, affecting the 
attentional subsystems of alerting, orienting and executive functioning. Especially, staying in 
an alert state without warning signals is almost impossible for individuals with ADHD. 
Deficits in attentional processes also involve higher-order processes such as inhibition of a 
pre-potent response, interference control and emotion regulation. Moreover, individuals with 
ADHD tend to show high moment-to-moment fluctuations, which not only explains their 
sudden, uncontrollable mood swings, but also signifies a considerable difficulty when 
assessing ADHD per psychometric assessment instruments. It is believed, that this deficiency 
is the result of abnormal error processing. Although delayed responses to errors have been 
suggested to be influenced by ADHD individuals‟ emotional states, there has been no 
association between error monitoring and anxious behaviour. 
Neurophysiological, a central deficiency of ADHD lies in the under-activated anterior 
cingulate, which is the reason why neurofeedback therapy focusses on this brain area in 
particular (Drechsler 2011). This explains the vast amount of symptoms in ADHD, for 
example in the study of Wu et al. (2006) examining the differences between ADHD 
individuals and normal controls in delay aversion; here, it evolved that while in both groups 
the ventral and dorsolateral prefrontal cortices as well as the insula were activated, only the 
normal controls showed an activation of the anterior cingulate and the hippocampus. As a 
consequence, ADHD individuals not only have problems in decision making, but also in 
memory and emotional processes. ERP studies and experiments using the Attentional 
Network Task (ANT) or Go/NoGo tasks replicated abnormalities in alerting in terms of 
slower response times to abrupt visual cues as well as difficulties in prefrontal response 
regulation and dealing with conflicting stimuli (Müller et al. 2011). Moreover, recent research 
about ADHD focus on cerebellar deficits and its connections to the basal ganglia, thalamic 
nuclei, prefrontal cortex, primary motor cortex and varied brainstem structures. Vance et al. 
(2006) were able to provide evidence for an increased cerebellar dysfunction in ADHD 
(combined type) compared to anxiety disorders. In concordance with the observations that the 
linkage of the cerebellum to the basal ganglia is important to consider, the latter has been 
found to be stronger impaired in ADHD than in anxiety disorders, leading to a higher motor 
speed; this includes positive effects, as well, such as a higher capability of motor fluency and 
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accuracy and increased choreoform and athetoid movements, which might hint to the bio-
evolutionary suggestion that the predisposition to ADHD might allow for better hunting 
abilities, having been an evolutionary advantage in former times. This is in concordance to 
the observation that in ADHD subjects, the behavioural activation system (BAS) is often 
higher activated accompanied by a greater impulsivity measure and a tendency to risk-seeking 
behaviour. In anxiety disorders, cognitive dysfunctions are very different from ADHD. For 
example, in OCD, planning and even attention are functioning normally, whereas spatial 
recognition and working memory as well as motor initiation (rather than inhibition, as in 
ADHD) are impaired. Social phobia has some overlaps with ADHD in terms of attentional 
problems, whereby socially phobics tend to focus on themselves, a problem not shared by 
ADHD patients. They also differ from ADHD populations in visuo-constructional functions. 
Moreover, OCD individuals usually display lower verbal creativity, whereas ADHD is 
characterized by higher-than-average abilities in creativity. Panic disorder with and without 
agoraphobia, social phobias as well as OCD are linked to impairments in episodic memory; 
ADHD individuals rather have problems with working memory (e.g.: Holmes et al. 2010). 
One of the main neurotransmitter involved in anxiety disorders is known to be serotonin, 
which also strongly influences our mood. Three main systems are involved in fear and 
anxiety: the septo-hippocampal system, the amygdala and the hypothalamus and 
periaqueductal grey (McNaughton et al. 2004). Further neurotransmitters involved in anxiety 
are acetylcholine and adrenaline; especially acetylcholine is responsible for common chronic 
stress-diseases due to a permanent hyper-activation of the hypothalamus–pituitary axis. On 
the contrary to ADHD patients, which display a tendency to spontaneous, impulsive decisions 
due to delay aversion, socially phobic individuals have difficulties in quick decision making 
and need more time for decisions than normal controls (Kaplan et al. 2006). 
There are also common neuropsychological features in ADHD and anxiety disorders. 
Schatz and Rostain (2006) pointed out that a state of nonspecific arousal provoked by the lack 
of rewarding signals in ADHD might increase the disposition towards anxious reactions. 
Likewise, when stronger focussing on threatening stimuli, the BIS (behavioural inhibition 
system) tends to be higher activated in ADHD patients due to the inability to focus on 
relevant input. Obviously, also people with anxiety disorders are strongly BIS-orientated. 
Moreover, anxiety can evoke ADHD like symptoms via the neurotransmitter acetylcholine, 
which plays an important role in a range of cognitive domains; across empirical methods, 
working memory, attention, episodic memory encoding, and spatial memory processing are 
repeatedly, found to depend upon acetylcholine for normal functioning (Newman et al. 2012). 
In concordance with these findings, children of anxious mothers have a higher risk for 
developing ADHD (Perrin et al. 1996). 
 
 
3.6. ADHD and Personality Disorders 
 
3.6.1. Prevalence 
Information on prevalence rates for personality disorders (PD) is sparse. Epidemiological 
studies on the prevalence of PD in the general population arrive at prevalence rates of 
between 4.4% and 15.7% (Coid et al. 2006; Lenzenweger et al. 2007; Samuels et al. 2002; 
Torgersen et al. 2001). In the US, estimated prevalence rates for the various types of PD as 
subdivided into the three DSM-IV/-5 Clusters, were 5.7% for Cluster A, 1.5% for Cluster B 
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and 6.0% for Cluster C (Lenzenweger et al. 2007). In the same study, 5.2% of the research 
population were found to meet diagnostic criteria for avoidant PD, 4.9% for schizoid, 3.3% 
for schizotypal, 2.4% for obsessive-compulsive, 2.3% for paranoid, 1.6% for borderline, 1% 
for anti-social, and 0% each for histrionic and narcissistic PD. With psychiatric patients, 
prevalence rates for PD of between 40% and 60% are markedly higher (Bohus et al. 2012; 
Newton-Howes et al. 2010). In a more recent study conducted in the United Kingdom, the 
following estimates of prevalence rates for PD in psychiatric patients were established: 16.5% 
for avoidant, 16.0% for dependent, 8.5% for borderline, 6.7% for obsessive-compulsive, 5.0% 
for paranoid, 3.2% each for anti-social and histrionic, and 2.8% for schizoid PD (Newton-
Howes et al. 2010). 
 
3.6.2. Differential Diagnosis 
Viewed from a phenomenological perspective, borderline personality disorder (BPD) and 
anti-social personality disorder (ASPD) show a certain symptoms overlap with ADHD, 
particularly in respect of impulsivity and emotional dysregulation. For this reason, these two 
types of PD warrant special attention, as only a very limited amount of specific studies on 
remaining PDs in the context of ADHD is available to date. An overview of the symptoms 
overlap between BPD, ASPD and ADHD is contained in Table 8 below. 
Similarly to BPD, adult ADHD, too, is characterised by impulsivity, extreme outbursts of 
rage or persistent inner tension, mood lability and emotional over-reactivity in stressful 
situations (Corbisiero et al. 2013; Matthies and Philipsen 2014; Prada et al. 2014; Wender 
1995). 
Additionally, low self-esteem and impaired social relationships are observed in both 
disorders (Matthies and Philipsen 2014; Newark et al. 2012). A marked difference between 
the symptoms of the two disorders is found predominantly in their respective onsets: whilst 
ADHD is a developmental disorder already diagnosable in childhood (before the age of 12), 
symptoms of BPD are first observed in adolescence, with a full diagnosis following in 
adulthood only (DSM-5). A further marked difference between the two disorders lies in a 
chronic suicidal tendency and a tendency to self-harm, both core symptoms of BPD (DSM-5). 
These symptoms play a minor role in relation to ADHD, where they are regarded as possible 
consequences of the disorder (e.g., within the context of a depressive disorder) rather than 
defining characteristics (Philipsen et al. 2006; Prada et al. 2014). In ADHD, the cardinal 
symptom is inattention, the presence of which is mandatory to establishing an ADHD 
diagnosis (DSM-5; Wender 1995). 
A similar relationship is found between ADHD and ASPD in relation to symptoms of 
lack of impulse control, emotional dysregulation and impaired interpersonal relationship 
problems. 
In addition, however, ADHD patients also show high-risk behaviour with a pronounced 
need to seek out novelty value (Philipsen et al. 2006), e.g., display of aggressive behaviour in 
road traffic (Barkley and Murphy 2010; Sobanski et al. 2013) and, in the case of prisoners 
with ADHD, delinquency (Gudjonsson et al. 2012; Moore et al. 2013; Storebø and Simonsen 
2013) in the accompanying absence of any sense of guilt or remorse (DSM-IV/-5). 
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Table 8. Symptomatic overlap and shared features between ADHD, BPD and ASPD 
(DSM-5; Utah-Criteria by Wender 1995) 
 
Symptom/feature ADHD1 BPD2 ASPD3 
Inattention    
Hyperactivity    
Inner restlessness    
Impulsivity    
Emotional dysregulation    
 Affective lability    
 Hot temper    
 Stress intolerance    
Disorganisation    
Interpersonal deficits    
Low self-esteem    
Risk behaviour    
Non suicidal self-injuries    
Chronic suicidality    
Chronic emptiness    
Dissociation    
Absence of repentance    
Substance abuse    
Note. 1Attention Deficit Hyperactivity Disorder; 2Borderline Personality Disorder; 3Antisocial 
Personality Disorder. 
: present. 
 
3.6.3. Comorbidity 
Prevalence rates for PD in ADHD patients are as high as 64.3% (Miller et al. 2008). In 
their recent study, Vidal et al. (2014) found that 24.78% of ADHD patients also met the 
diagnostic criteria for a PD. Cumyn et al. (2009), in a larger study with 335 ADHD patients, 
identified an overall figure of 50.7% of patients with a PD, with breakdown percentages of 
27.68% fulfilling the criteria for compulsive PD, 24.11% for BPD, 12.54% for avoidant PD, 
12.50% for narcissistic PD, and 5.07% for ASPD. The remaining types of PD, however, were 
also found concurrent with ADHD. In Williams et al. (2010) for example, 11% of their small 
sample of 47 ADHD patients tested positive for depressive PD, 9% each for paranoid and 
passive-aggressive PD, 6% for dependent PD and 2% for histrionic PD. Matthies et al. (2011) 
also found schizoid PD in 6.6%, and schizotypal PD in 6.7% of their research population 0). 
In general, patients tested positive for more than one PD (cf. Matthies et al. 2010; Williams et 
al. 2010). This leads to the conclusion that it is predominantly PD types from DSM-IV/-5 
Clusters B (dramatic-emotional) and C (anxious-avoidant) which tend to co-occur with 
ADHD (Matthies et al. 2011). 
Two types of PD which are closely linked to adult ADHD are BPD and ASPD. These 
two disorders show considerable overlap with ADHD both in respect of symptoms as well as 
at a neurobiological level. The more consistent prevalence rates for comorbidity are found 
between BPD and ADHD and are estimated at between 18.3% - 38.1% (Cumyn et al. 2009; 
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Ferrer et al. 2010; Instanes et al. 2013; Matthies et al. 2011; Miller et al. 2008). The estimated 
prevalence rate for comorbid ASPD among ADHD patients of 40.3%, however, was even 
higher (Instanes et al. 2013). In criminal offenders with ADHD the estimated percentage rate 
is reported to be higher still (cf. Gudjonsson et al., 2012; Moore et al. 2013). 
Philipsen et al. (2008), in their study on a clinical population, reported that 41.5% of 
women diagnosed with BPD had displayed ADHD symptoms in childhood, with 16.1% 
proceeding to meet the diagnostic criteria for ADHD. The study also suggested that the higher 
the number of current adult BPD symptoms patients were able to relate, the greater the 
likelihood of a former presence of childhood ADHD in these patients, and that, as a 
consequence, childhood ADHD might pose a possible risk for the development of BPD in 
later life. Compared to patients diagnosed with BPD only, ADHD patients with comorbid 
BPD were reported to be at an increased risk of developing suicidal tendencies and additional 
mental disorders such as anxiety and substance disorders as well as ASPD. ADHD patients 
with comorbid BPD also told of higher incidence rates of emotional abuse than did patients 
diagnosed with BPD only (cf. inter alia Storebø and Simonsen 2014). In comparison with 
BPD patients and a healthy control group, ADHD patients displayed more BPD symptoms 
than the healthy controls. Self-harming behaviour and emotional dysregulation were, 
however, less frequently observed in ADHD patients with comorbid BPD than in patients 
diagnosed with BPD only (Philipsen et al. 2008). Findings of further studies also indicated 
that ADHD patients with comorbid BPD showed higher levels of impulsivity and aggressive 
behaviour than patients diagnosed with either ADHD or BPD only, or healthy controls 
(Prada, et al. 2014). A connection between ADHD and BPD was also found at a genetic level 
(Distel et al. 2011) with an estimated phenotypic correlation between ADHD and BPD 
symptoms of r = .59, of which 49% were attributable to genetic factors. 
The development of ASPD is an aspect under consideration in connection with ADHD 
and social conduct disorder (SCD). Childhood ADHD with or without comorbid SCD appears 
to enhance the overall clinical symptomatology and with greater probably leads to the 
development of a later ASPD (Retz et al. 2013; Storebø and Simonsen 2013). Children with 
ADHD and comorbid SCD run an additional enhanced risk of slipping into crime and 
delinquency at a later stage in their lives (Storebø and Simonsen 2013). Emotional neglect, 
parental divorce, early separation from primary carers or attachment figures as well as past 
suicide attempts appear to be more frequent in persons with ASPD and comorbid ADHD; 
especially the level of impulsivity appears to feature as a prominent factor in the dynamics of 
the association between these two disorders (Storebø and Simonsen 2013). 
 
3.6.4. Neuropsychology 
The described symptoms overlap between ADHD, BPD and ASPD also manifests itself 
in a neuropsychological context. The neuropsychological deficits common to all three 
disorders are located in the prefrontal cortex (the core region of attention mechanisms) and in 
the orbito-frontal cortex (the core region of impulsivity and emotional dysregulation) (Dolan 
2012; Philipsen 2006). ADHD as well as BPD patients display impaired impulse control and 
appear to suffer also from response inhibition, particularly in stressful situations (Krause-Utz 
et al. 2013; Matthies and Philipsen 2014; van Dijk et al. 2014). Impulse control in BPD 
patients, however, becomes particularly impaired in the face of emotional and interpersonal 
relationship difficulties or in the presence of a comorbid ADHD (Sebastian, Jacob, Lieb and 
Tüscher 2013). While with BPD patients lack of impulse control indicates primarily 
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prefrontal impaired functioning in orbito-frontal, dorsomedial and dorsolateral brain areas, 
impaired activity in ADHD patients tends to be more concentrated in ventrolateral and medial 
prefrontal regions (Sebastian et al. 2014). Only few studies so far have compared the 
neuropsychological mechanisms of ADHD and BPD. Krause-Utz et al. (2013), in their study 
of various groups (BPD, BPD with and without ADHD, ADHD, and healthy controls), found 
that response inhibition (assessed through the Immediate and Delayed Memory Task; 
Dougherty and Marsh 2003) was particularly impaired in patients with BPD and co-occurring 
ADHD. These findings, however, stand in contradiction to a study by van Dijk et al. (2014), 
who observed response inhibition (assessed through the Expectancy AX-CPT Task) in both 
ADHD as well as BPD patients (regardless of whether comorbid BPD or ADHD respectively 
was present or not). 
Emotional dysregulation has, until now, been generally defined as core to BPD symptoms 
(Matthies and Philipsen 2010) and has only in the past few years become the subject of more 
intensive research in the context of ADHD (Corbisiero et al. 2013). In ADHD, inattention 
appears to play an important role in the regulation of emotions, yet the neuropsychological 
mechanisms of the correlation between inattention and emotional dysregulation remains still 
unclear (Shaw et al. 2014). In the case of BPD, however, it is assumed that in the regulation 
of emotions, attention deficits play a less decisive role (Lampe et al. 2007). 
The neuropsychological deficits in persons with ASPD are, similarly to ADHD, present 
in executive functions, although empirical evidence to this effect remains scarce: in particular, 
difficulties with planning ability, behavioural inhibition and set shifting were observed (Dolan 
2012). A recently published study on ASPD patients and ADHD with ASPD patients 
investigated their ability to recognise emotions (joy and happiness, sadness, fear, disgust, 
anger, surprise, and neutral facial expression), which was measured through the Emotion 
Recognition Test containing facial expressions from Ekman and Friesen‟s series (Ekman 
1999). The two groups displayed significant differences only in respect of the ability to 
recognise the emotion of disgust (Bagcioglu et al. 2014). 
 
 
SUMMARY AND PERSPECTIVES 
 
The clinical diagnostics of ADHD represent a complex process. In contrast to most other 
mental disorders, establishing a differential diagnosis in ADHD cases necessitates 
consideration of a lifespan in its entirety (not dissimilar to personality disorders). There is 
therefore a plethora of information to be gathered, to which end an increasingly large variety 
of assessment tools have become available. As well as information from patients themselves 
and from third parties, various additional sources of data require consideration and evaluation 
in the process. The diagnostic criteria, which meanwhile have been adapted in DSM-5 to 
adulthood, are less difficult to explore than in other disorders, making hardly any 
psychopathological knowledge necessary. Yet, partially overlapping symptom areas and the 
potential comorbidity of ADHD with other disorders pose particular challenges in 
establishing a differential diagnosis. On the one hand, the results of a variety of studies 
containing comprehensive accounts of clinical experiences offer a foundation upon which to 
base a reliable diagnosis. Conversely, however, a host of questions still remains unanswered. 
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In particular with regard to the relationship between ADHD and schizophrenia, further 
empirical research is required to shed light on the many open issues involved. 
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